What is the truth about Corona treatment using the blood of recovered patients?
The results of clinical trials in Argentina showed that the use of blood plasma of people recovering from Covid 19 in treating patients has no significant benefit, and the study was published in the New England Journal of Medicine that treatment called convalescent plasma does not have any effect on patients like any placebo treatment received by participants in the trials.
And last October, a small study in India indicated that convalescent plasma improved some symptoms in patients with Covid-19, such as shortness of breath and feeling tired, but it did not reduce the risk of death or deterioration of the disease after 28 days.
The study, which took place in Argentina, included 333 patients being treated in hospital for acute pneumonia due to their infection with the Coronavirus, and they were divided randomly to receive convalescent plasma treatment or placebo.
After 30 days, the researchers found no significant difference in symptoms or health status. The mortality rate was roughly the same, at 11 percent in the convalescent plasma group and 11.4 percent in the placebo group, a difference not considered to be statistically significant.